AiViva BioPharma

Ophthalmology Innovation Source (OIS) XIV
2024-11-22 - 2024-11-23 | Omni Hotel San Diego, 675 L Street, San Diego, CA, 92101, United States
AiViva presenting with over 150 companies at OIS XIV Ophthalmology Innovation Summit.
This event unites many capital, clinical, and corporate leaders presenting clinical insights, anterior and posterior ophthalmology segments both. We look forward to learning, networking and collaborating at OIS Summit.

AiViva Excited to Attend Eyecelerator @ AAO 2024
2024-10-17 | McCormick Place, Chicago, IL, United States
Eyecelerator @ AAO 2024
Held twice per year, Eyecelerator conferences provide a full day of KOL-driven programs highlighting industry advancements, investment trends, and innovative new products disrupting eye care. There are valuable opportunities to network and explore new market potentials. Dozens of company showcases presenting novel clinical treatments and emerging technologies that are shaping the future of ophthalmology and expanded opportunities for audience questions and participation.
Learn more at: https://www.eyecelerator.com/

AiViva’s Abstract for 2024
Title: Ocular and Systemic Pharmacokinetic Profiles Following Periocular Administration of AIV007 Gel Formulation
Authors: Yi Zhao and Diane DS Tang-Liu

MedInvest Biotech & Pharma Investor Conference
2024-09-18 - 2024-09-19 | O’Melveny, 1301 6th Avenue, New York, NY, 10019, United States
AiViva attending the upcoming meeting of the MedInvest Biotech & Pharma Investor Conference will be held in New York City, NY on September 18-19, 2024.
The conference will feature two days of company presentations, panel discussions, and keynote talks. Both in-person and virtual meetings will be taking place during the two days of the conference. The presenting companies are developing and/or commercializing technologies across a broad spectrum of indications, including oncology, immunology, neurology, cardiology, diabetes, infectious diseases, pulmonary diseases, autoimmune diseases, respiratory diseases, urology, endocrinology, dermatology, pain management, and many others.

AiViva BioPharma at 2024 LSX World Congress USA
2024-09-11 - 2024-09-12 | Hynes Convention Centre, 900 Boylston Street, Boston, MA, 02115, United States
Reach out to Shane at this meeting, or through LinkedIn, to explore strategic partnerships in ophthalmology and/or dermatology.

Find out more: https://informaconnect.com/lsx-world-congress-usa/

AiViva at 2024 Bio Asia-Taiwan
2024-07-25 - 2024-07-28 | Bio Asia-Taiwan 2024, Taipei Nangang Exhibition Center, Hall 2 (TaiNEX2 7F), Taipei, Taiwan
The Conference will focus on five major areas: Innovation Forum, Investment Summit, Regional Collaboration Forum, Company Presentations, and Satellite Symposia.
BIO Asia–Taiwan 2024 will again feature the renowned BIO One-on-One Partnering™ platform, an easy-to-use online meeting scheduling system to search for and identify potential partners, collaborators, investors and in- and out-licensing opportunities. Face-to-face meetings will be held over private and secure video links 24 hours a day during the event period. With over 5,500+ meeting requests made via the system during BIO Asia–Taiwan 2023 and with an 68% increase in meetings scheduled over the year before, partnering is again expected to be a highly popular activity.
BIO Asia–Taiwan 2024 will showcase Taiwan’s growing digital advantage in the biomed sector and highlight advances in biotech, pharmaceutical, medical devices, precision medicine, AI applications, ICT, IoT technologies, and new healthcare/medical investment opportunities.
Agenda: BIO Asia–Taiwan 2024 亞洲生技大會

AiViva BioPharma Presents Two Abstracts/Presentations at ARVO 2024
2024-05-05 - 2024-05-09 | ARVO 2024, 705 Pike Street, Seattle, WA, 98101-2310, United States
AiViva BioPharma is excited to present two Abstract/Presentations at The Association for Research in Vision & Ophthalmology (ARVO) conference in Seattle, Washington on May 5 and May 6, 2024.
The following will be presented by AiViva executives:
Presentation Number – Posterboard Number: 237 – B0300
Abstract/Presentation Title: Periocular injection of AIV007 in the Treatment of Macular Edema due to Neovascular Age-related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME): Preliminary Results of the Phase 1 Clinical Trial
Presenter: Yi Zhao, MD, PhD
Presentation Type: Poster Session
Session Number: 108
Session Title: AMD-1 (anti-VEGF)
Session Date/Times: May 5, 2024 from 8:00 AM to 9:45 AM

Presentation Number – Posterboard Number: 1946 – B0309
Abstract/Presentation Title: AIV007 Is a Potent Anti-angiogenic Agent with Anti-fibrotic Effect
Presenter: Yi Zhao, MD, PhD
Presentation Type: Poster Session
Session Number: 225
Session Title: AMD new drugs, delivery systems and mechanisms of action
Session Date/Times: May 6, 2024 from 8:30 AM to 10:15 AM

If you attend ARVO 2024, please stop by and say hello! We look forward to meeting you.
About ARVO: https://www.arvo.org/globalassets/arvo/about/press-room/arvo-fact-sheet.pdf
ARVO Schedule: https://www.arvo.org/globalassets/annual-meeting/arvo-2024/2024-schedule-at-a-glance.pdf

AiViva BioPharma presents at the Global Life Science Partnering & Investor Conference
2024-02-28 15:30 - 17:00 UTC | Global Life Science Partnering & Investor Conference, THE LODGE AT TORREY PINES, LaJolla, CA, United States
AiViva BioPharma presents at the Global Life Science Partnering & Investor Conference presented by Biocom California. Location at The Lodge at Torrey Pines at 4:00 p.m.
See links below.

National Taiwan University Conference
2022-05-07 | CA
CEO & President, Dr. Diane Tang-Liu, will be keynote speaker on May 7, 2022, at National Taiwan University (NTU). Recognized as a Distinguished NTU School of Pharmacy Alumnus, Dr. Tang-Liu’s presentation topic is “Transforming the Standard of Care for Age-Related Macular Degeneration to Address Unmet Medical Needs.”
Dr. Tang-Liu serves as a Scientific Advisor to Perfuse Therapeutics, Taiwan’s Supra Integration, and Incubation Center, Academia Sinica, and the National Taiwan University-Stanford University SPARK program. In 2009, she received a Distinguished Alumni Achievements Award from the School of Pharmacy, National Taiwan University, She was elected Fellow of American Association of Pharmaceutical
Scientists and American College of Clinical Pharmacology. Diane received B.S. in Pharmacy from National Taiwan University, and Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco.

MAGI’s Clinical Research Conference
2022-05-05 | CA
Dr. Deecher chairing a session on the MAGI’s Clinical Research vConference on May 5, 2020, from 2:30-3:30pm ET. Subject matter on “The ‘Tiny Details’ that Can Wreak Havoc with a Protocol. What sponsors, sites and CROs should look for in a protocol.” #MAGIworld

MAGI’s Clinical Research Conference
2020-04-27 | CA
AiViva participated on the MAGI’s Clinical Research vConference. Dates of conference on April 26-29 and May 3-6, 2020. Darlene Deecher, Head of Clinical Development at AiViva, will be discussing “New Times, New Solutions: Key Challenges for Small Sponsors” on Tuesday, April 27, 11:00-12:00pm ET
